Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Dusseldorf - Delayed Quote EUR

Carisma Therapeutics Inc. R (W2J.DU)

Compare
0.4218
+0.0004
+(0.09%)
At close: February 21 at 7:30:41 PM GMT+1
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
20,268
14,919
9,834
--
--
Operating Expense
87,042
103,650
65,996
40,794
28,378
Operating Income
-66,774
-88,731
-56,162
-40,794
-28,378
Net Non Operating Interest Income Expense
2,777
1,936
-3,145
10
29
Other Income Expense
--
-84
-1,919
--
--
Pretax Income
-63,997
-86,879
-61,226
-40,784
-28,349
Net Income Common Stockholders
-63,800
-86,879
-61,226
-40,784
-28,349
Diluted NI Available to Com Stockholders
-63,800
-86,879
-61,226
-40,784
-28,349
Basic EPS
-1.52
-2.59
-1.52
-1.01
-0.70
Diluted EPS
-1.52
-2.59
-1.52
-1.01
-0.70
Basic Average Shares
41,134.9150
33,524.1970
40,254.6660
40,254.6660
40,254.6660
Diluted Average Shares
41,134.9150
33,524.1970
40,254.6660
40,254.6660
40,254.6660
Total Operating Income as Reported
-66,774
-88,731
-56,162
-40,794
-28,378
Total Expenses
87,042
103,650
65,996
40,794
28,378
Net Income from Continuing & Discontinued Operation
-63,800
-86,879
-61,226
-40,784
-28,349
Normalized Income
-63,800
-86,795
-59,307
-40,784
-28,349
Interest Income
--
1,936
--
10
29
Interest Expense
--
--
3,145
--
--
Net Interest Income
2,777
1,936
-3,145
10
29
EBIT
-66,774
-88,731
-58,081
-40,794
-28,378
EBITDA
-63,367
-85,894
-56,188
-40,112
-27,930
Reconciled Depreciation
3,407
2,837
1,893
682
448
Net Income from Continuing Operation Net Minority Interest
-63,800
-86,879
-61,226
-40,784
-28,349
Total Unusual Items Excluding Goodwill
--
-84
-1,919
--
--
Total Unusual Items
--
-84
-1,919
--
--
Normalized EBITDA
-63,367
-85,810
-54,269
-40,112
-27,930
Tax Rate for Calcs
--
--
--
--
0.0001
12/31/2020 - 4/9/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

S09.BE Sutro Biopharma Inc
1.7100
-2.84%
 
37Z.BE Allakos Inc
0.2700
-1.35%
 
8AW0.MU Ocean Biomedical Inc
0.1330
-1.48%
 
8AW0.SG Ocean Biomedical Inc
0.1210
+12.04%
 
8AW0.BE Ocean Biomedical Inc
0.1220
-6.15%
 
8AW0.F Ocean Biomedical, Inc.
0.1200
-4.76%
 
0M4.MU Mersana Therapeutics Inc
0.5106
-7.60%
 
S09.MU Sutro Biopharma Inc
1.7600
0.00%
 
S09.F Sutro Biopharma, Inc.
1.6800
-3.45%
 
PBMWW Psyence Biomedical Ltd.
0.0186
-5.58%